| http://purl.uniprot.org/citations/7734359 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Kakkar V.V."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Lindo V.S."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Learmonth M."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/pages | "589-601"xsd:string |
| http://purl.uniprot.org/uniprot/P01008 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/7734359 |
| http://purl.uniprot.org/uniprot/P01008#attribution-1843C703C47798DD002971F6CD90698F | http://purl.uniprot.org/core/source | http://purl.uniprot.org/citations/7734359 |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Morris H.R."xsd:string |
| http://purl.uniprot.org/uniprot/#_kb.P01008_up.isolatedFrom_tissue.800 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/7734359 |
| http://purl.uniprot.org/uniprot/#_P01008-citation-7734359 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/7734359 |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Panico M."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/7734359 |
| http://purl.uniprot.org/citations/7734359 | http://purl.org/dc/terms/identifier | "doi:10.1111/j.1365-2141.1995.tb08368.x"xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Melissari E."xsd:string |
| http://purl.uniprot.org/uniprot/P01008#SIP036410C8BD352C63 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/7734359 |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/title | "Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/volume | "89"xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/7734359 |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/author | "Zappacosta F."xsd:string |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/date | "1995"xsd:gYear |
| http://purl.uniprot.org/citations/7734359 | http://purl.uniprot.org/core/name | "Br. J. Haematol."xsd:string |